Teva Announces Community Partnership with Lighthouse

Teva Announces Community Partnership with Lighthouse

PHILADELPHIA, Jan. 26 /CSRwire/ – Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the U.S. organizations selected as part of Teva’s 2017-18 Community Partnership Program. Now in its fourth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers and Science, Technology, Engineering and Mathematics (STEM) programs in geographic areas where Teva has a business presence.

“We are excited to partner with organizations that are committed to improving the lives of patients on a daily basis,” said Denise Bradley, Senior Vice President, Global Corporate Reputation. “Working with these inspiring organizations allows us to provide meaningful assistance to patients in need as well as our commitment to ensuring Teva employees can achieve their fullest potential by supporting those patients.”

 2017-18 Community Partners:

Pennsylvania (Greater Philadelphia Area)

  • Bringing Hope Home
  • PHL Ronald McDonald House
  • Mazzoni Center
  • Julia’s Grace Foundation
  • Ryan’s Case for Smiles
  • Mitzvah Circle Foundation
Kansas City Area

  • Shadow Buddies Foundation
  • Children’s Mercy Hospital
  • YMCA of Greater Kansas City


Northern New Jersey/New York City

  • Bryan’s Dream Foundation
  • Community Hope


Cincinnati, OH

  • Cincinnati Children’s Hospital Medical Center
  • Lighthouse Youth Services
  • American Cancer Society
Forest, VA

  • American Cancer Society
  • Free Clinic of Central Virginia
  • Children’s Miracle Network Hospitals
Salt Lake City, UT

  • Ronald McDonald House Charities
  • Rocky Mountain Care Foundation
  • American Foundation for Suicide Prevention
South FL

  • Kid’s in Distress
  • Juvenile Diabetes Research Foundation
  • Youth Automotive Training Center

Click here to learn more about Teva’s 2017-18 Community Partners.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva’s net revenues in 2015 were $19.7 billion. For more information, visit


For more information, please contact:

Phone: 4846125407
For more from this organization: